Welcome to our dedicated page for agilon health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on agilon health stock.
agilon health, inc. (NYSE: AGL) is a transformative health care partner dedicated to redefining primary care by enabling physicians with the tools, technology, and support needed to deliver high-quality care. agilon health forms strategic long-term partnerships with physician groups to transition them to a value-based care model, aiming to improve patient outcomes while reducing costs. The company operates a purpose-built platform that supports over 3,000 primary care physicians (PCPs) across more than 30 communities, providing care to over 700,000 senior patients.
agilon health’s core business revolves around empowering physicians to create a Medicare-centric, globally capitated line of business. The company derives its revenue from providing medical services under full-risk contracts, which aligns financial incentives with patient health outcomes. agilon health has demonstrated significant growth, achieving a 75% increase in revenue to $1.22 billion, with Medicare Advantage membership surging by 58% to 420,300 members.
The company's recent achievements include the publication of a peer-reviewed study on its value-based palliative care program, showcasing improved patient-centered outcomes. Additionally, agilon health has successfully expanded its Physician Network with new partnerships in Kentucky, Minnesota, Illinois, and North Carolina, further solidifying its presence in the U.S. healthcare market.
Financially, agilon health has shown resilience and adaptability. Despite challenges, the company has maintained strong revenue growth and continues to make progress in executing its targeted action plans to drive profitability and enhance operational efficiency. agilon health’s balance sheet reflects a solid financial position, with significant cash reserves and manageable debt levels, positioning the company for sustained growth and long-term success.
agilon health stands out in the healthcare sector by focusing on a value-based care model that prioritizes patient health over service volume. This approach not only benefits patients but also supports physicians in maintaining their independence and achieving better health outcomes for their patients.
agilon health, inc. (NYSE: AGL) has announced a public offering of 17,000,000 shares of its common stock, priced at $30.00 per share, from certain selling stockholders. The offering is expected to close on September 14, 2021, pending customary conditions. Notably, agilon health will not receive any proceeds from this secondary offering. The underwriters have the option to purchase an additional 2,550,000 shares. Leading managers for this offering include J.P. Morgan, Goldman Sachs, and BofA Securities.
agilon health, inc. (NYSE: AGL) has announced a secondary public offering of 17,000,000 shares by certain selling stockholders, with a potential additional 2,550,000 shares for underwriters. The company will not receive proceeds from the offering, which has lead managers including J.P. Morgan, Goldman Sachs, and BofA Securities. Additionally, 714,011 shares held by company officers and directors will be available for sale due to a waiver of a lockup restriction. A registration statement with the SEC has been filed, and details can be obtained from the lead managers.
agilon health, inc. (NYSE: AGL) will participate in two major investor conferences: the Wells Fargo Virtual Healthcare Conference on September 9 at 10:40 AM ET and the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 5:00 PM ET. Both events will include fireside chat presentations, accessible through a live webcast on agilon's investor relations website. The company focuses on improving healthcare for seniors by empowering primary-care physicians with essential support and resources, fostering healthier communities and better patient care.
Agilon Health, Inc. (NYSE: AGL) reported a 70% increase in total revenue to $499 million for Q2 2021, with a year-to-date growth of 56%. Membership rose by 45% year-over-year, reaching approximately 181,700 members. However, the company faced a net loss of $299 million, a significant rise from the $8 million loss in 2020, primarily due to $275 million in stock compensation expenses. Medical Margin decreased to $55 million, and adjusted EBITDA was negative $2 million compared to a positive $14 million last year. Outlook for Q3 2021 projects revenues between $450 million and $453 million.
agilon health, inc. (NYSE: AGL) has announced it will release its financial results for Q2 2021 after market close on August 4, 2021. A conference call is scheduled for August 5, 2021, at 8:30 AM ET to discuss these results. The call can be accessed via phone or through their investor relations website. agilon health focuses on transforming healthcare for seniors, empowering primary-care physicians by providing essential support in managing their patients' overall health, which contributes to healthier communities.
agilon health (NYSE: AGL) has appointed Karen McLoughlin to its board of directors. A former CFO of Cognizant Technology Solutions, she boasts significant financial expertise, having contributed to the company's growth from $365 million to nearly $17 billion in revenue. McLoughlin's 17-year tenure at Cognizant included oversight of global finance and strategic initiatives. Board chairman Ron Williams highlighted her skills in digital transformation as critical for agilon's future. CEO Steve Sell emphasized her potential to enhance the company's platform, aligning with agilon's mission to support primary care for seniors.
agilon health, inc. (NYSE: AGL) announced its participation in two upcoming investor conferences. The company will present at the William Blair 41st Annual Growth Stock Conference on June 3 from 3:40-4:10 PM ET and at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8 from 2:10-2:50 PM ET. Interested investors can listen to live webcasts of both events on the company's investor relations page. Replays will also be available after the presentations.
Agilon Health, Inc. (NYSE: AGL) reported a strong first quarter for 2021, achieving total revenues of $413 million, a 42% increase compared to the previous year. Membership numbers grew by 35%, reaching approximately 165,300, with further increases expected due to a new group Medicare Advantage contract. Although they reported a net loss of $14 million, adjusted EBITDA improved to $4 million, up from $3 million in 2020. The company plans to support growth with IPO proceeds, aiming for 175,000 to 177,000 members by Q2 2021.
FAQ
What is the current stock price of agilon health (AGL)?
What is the market cap of agilon health (AGL)?
What is agilon health's core business?
How does agilon health generate revenue?
What recent achievements has agilon health accomplished?
How is agilon health performing financially?
What is agilon health's approach to healthcare?
How many physicians are part of agilon health's network?
What is the significance of agilon health's value-based care model?
What challenges has agilon health faced recently?
What are agilon health's plans for future growth?
How does agilon health support its physician partners?
